Purpose To assess whether dysglycemia diagnosed during severe acute respiratory
syndrome coronavirus 2 pneumonia may become a potential public health problem after …

Aim Diabetes has been identified as a risk factor for poor outcomes in patients with COVID‐
19. We examined the association of hyperglycaemia, both in the presence and absence of …

Objective Diabetes is a known risk factor for mortality in Coronavirus disease 2019 (COVID-
19) patients. Our objective was to identify prevalence of hyperglycaemia in COVID-19 …

Hyperglycemia with or without blood glucose in diabetes range is an emerging finding not
uncommonly encountered in patients with COVID-19. Increasingly, all evidence currently …

Certain chronic comorbidities, including diabetes, are highly prevalent in people with
coronavirus disease 2019 (COVID-19) and are associated with an increased risk of severe …

Summary Type 2 diabetes (T2D) is a major comorbidity of COVID-19. However, the impact of
blood glucose (BG) control on the degree of required medical interventions and on mortality …

Diabetes and hyperglycemia occurring during COVID-19 era have implications for COVID-
19 related morbidity/mortality. In this brief review, we have attempted to categorise and …

Introduction: Uncontrolled glycemia is a well-recognized predictor of severity and deaths in
previous respiratory viral outbreaks. We aimed to describe the characteristics and clinical …

Patients with coronavirus disease 2019 (COVID-19) are reported to have a greater
prevalence of hyperglycaemia. Cytokine release as a consequence of severe acute …

Aims To evaluate glycaemic profiles of COVID-19 patients without diabetes receiving
dexamethasone and determine factors associated with hyperglycaemia. Methods All …